Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer

Antiangiogenic therapy has recently emerged as a highly promising therapeutic strategy for treating hepatocellular carcinoma (HCC). However, the only clinically approved systemic antiangiogenic agent for advanced HCC is sorafenib, which exerts considerable toxicity. Moreover, acquired resistance to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Ther
Huvudupphovsmän: Liu, Jia-Yu, Chiang, Tsaiyu, Liu, Chun-Hung, Chern, Guann-Gen, Lin, Ts-Ting, Gao, Dong-Yu, Chen, Yunching
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2015
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817943/
https://ncbi.nlm.nih.gov/pubmed/26278330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.147
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk